gvtcx

NHS Framework Agreement for Glatiramer acetate injection - North of England

NHS England Published 19 Jun 2018 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£10,432,586
Statuscomplete
Category (CPV) 33600000
RegionNorth East, North West, Yorkshire and the Humber
Deadline20 Jul 2018
Contract start1 Sept 2018
Contract end29 Feb 2020
Procedureopen
SME suitableYes
OCIDocds-b5fd17-ed6126f2-1b57-433b-a8db-a858839857f8

Awards (2)

This procurement was awarded to 2 suppliers. Values shown are per-award; the notice total is £10,432,586.

SupplierValueDateStatus
Generics [UK] ta Mylan shared £0 28 Aug 2018 active
Teva UK Ltd shared £0 28 Aug 2018 active

description

NHS Framework Agreement for the supply of Glatiramer Acetate Injection to the North of England region.

Offer reference number: CM/PHR/18/5565

Period of framework agreement: 1 September 2018 - 29 February 2020 with an option to extend at the Authority's discretion for up to 24 months

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
1 Oct 2018 Award (award) · 1700f2ee-4201-43e9-9e5c-41a3e928faee-243479

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.